ClinicalTrials.gg
Sign In

Glioma clinical trials

The registry lists 1,452 studies for Glioma across more than 10 countries. 349 are recruiting or about to start. 650 of them are mainly about Glioma (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12. Counting its 7 narrower conditions too, such as Glioblastoma: 3,402 studies, 796 open.

ClinicalTrials.gov finds 3,592 studies for Glioma. How that becomes 1,450 here

This page counts the studies the registry files under Glioma, and those it files under no condition that list Gliomathemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 3,592Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −1,883Filed under a narrower condition, counted on its own pageGlioblastoma 1,473 · Astrocytoma 159 · Medulloblastoma 137 · Diffuse Intrinsic Pontine Glioma 48 · Ependymoma 32 · Oligodendroglioma 17 · 1 more
  3. −165List Glioma as a condition, but the registry did not file them under itMost often written as “Low-Grade Glioma” (19), “Low Grade Glioma” (10), and “Low Grade Glioma of Brain” (9). The registry filed 112 of them under no condition at all, and the others under other conditions only, most often Brain Neoplasms (15) and Optic Nerve Glioma (8).
  4. −94Match it another way81 name it in the title, 6 in a keyword, and 7 by a synonym or other text the search reads.
  5. 1,450The count on this page

Get an email when these change. Save the Glioma studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
626
Recruiting
267
Terminated
157
Status unknown
126
Active, not recruiting
112
Not yet recruiting
75

Phase

Phase 1
492
Phase 2
456
Early Phase 1
70
Phase 3
51
Phase 4
7

Where

United States
851
China
161
France
115
Canada
86
Germany
69
Italy
61

Who runs them

National Cancer Institute (NCI) (80) · Duke University (47) · M.D. Anderson Cancer Center (30) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (26) · Memorial Sloan Kettering Cancer Center (22) · Mayo Clinic (20) · Huashan Hospital (19) · Wake Forest University Health Sciences (17)

What is being tested here

Drugs under test in Glioma studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Temozolomide135112
Bevacizumab4244
Nivolumab4013
Trametinib4111
Dabrafenib318
Safusidenib315
Aminolevulinic Acid2316
Everolimus2010
Olaparib208
Fluorodopa F 18218

Drug classes tested here Alkylating agents 16 open · Tyrosine kinase inhibitors (TKIs) 10 open · Immune checkpoint inhibitors 9 open · Angiogenesis inhibitors 4 open · PARP inhibitors 4 open

Coming up

18phase 3 studies under way
152studies finish main data collection within a year5 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 267 Glioma studies recruiting now, 164 (61%) set no upper age limit and 57 (21%) stop at 75 or younger. 63 (24%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 15 (6%) take healthy volunteers.

Recruiting studies that take each age, of 267
AgeWomenMen
1055 (21%)55 (21%)
18258 (97%)258 (97%)
30242 (91%)242 (91%)
40233 (87%)233 (87%)
50234 (88%)234 (88%)
65230 (86%)230 (86%)
75221 (83%)221 (83%)
85190 (71%)190 (71%)

Across all 1,452 studies, recruiting or not: 24% stop at 75 or younger and 14% at 65; 21% take children; <1% are for women only and <1% for men only; 4% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Glioma studies take

Of 213 phase 1 interventional studies under Glioma, half reached primary completion within 59 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 159 mo36–88 · 213 studies62 mo42–121 · 47 studies59 mo36–87 · 166 studies
Phase 1/266 mo48–104 · 70 studies—68 mo48–104 · 44 studies
Phase 254 mo40–88 · 131 studies—55 mo41–89 · 108 studies
Interventional, no phase58 mo34–114 · 142 studies—61 mo36–114 · 131 studies
Observational60 mo29–104 · 123 studies—67 mo33–104 · 113 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting4

Stopped2

Newly registered5

Studies

Recruiting first, then most recently updated. Showing 50 of 1,452. Browse all 1,452 → or search them.